Curtis L. Scribner

Lassa Fever

Joseph B. McCormick, I. J. King, P. A. Webb et al. · New England Journal of Medicine · 1986 · 991 citations

Lassa Fever, Virus Epidemiology, Medicine +13

OLT1177, a β-sulfonyl nitrile compound, safe in humans, inhibits the NLRP3 inflammasome and reverses the metabolic cost of inflammation

Carlo Marchetti, Benjamin J. Swartzwelter, Fabia Gamboni et al. · Proceedings of the National Academy of Sciences · 2018 · 520 citations · Full text

Dapansutrile, an oral selective NLRP3 inflammasome inhibitor, for treatment of gout flares: an open-label, dose-adaptive, proof-of-concept, phase 2a trial

Viola Klück, Tim Jansen, M. Janssen et al. · The Lancet Rheumatology · 2020 · 257 citations · Full text

Anti-inflammatory, Gouty Arthritis, Pharmacology +8

Genetic analysis of autoimmune gld mice. I. Identification of a restriction fragment length polymorphism closely linked to the gld mutation within a conserved linkage group.

Michael F. Seldin, Herbert C. Morse, J P Reeves et al. · The Journal of Experimental Medicine · 1988 · 168 citations · Full text

Genetics, Immunology, Molecular Genetics +16

NO EVIDENCE FOR INCREASED RISK OF LASSA FEVER INFECTION IN HOSPITAL STAFF

Charles G. Helmick, Curtis L. Scribner, P. A. Webb et al. · The Lancet · 1986 · 66 citations

Healthcare-associated Infection, Clinical Epidemiology, Disease Outbreak +6